Prof. Dr. Ulf Teichgräber

08/2021

Prof. Dr. Ulf Teichgräber

mint Lesion™ is an asset for the professionality and motivation of radiological tasks. Since the introduction of this software we have structured our evaluation procedure for clinical trials and are experiencing an effective improvement in the daily routine of oncological therapy evaluation.

Related Resources

Objective, reproducible, and trustworthy data in clinical trials with imaging endpoints

11/2020

Dr. Anthony Tolcher, medical oncologist and CEO of NEXT Oncology, spoke to us about objectivity as one of the biggest challenges in clinical trials…

University Hospital Jena: Study evaluated response rate and safety in patients with HCC treated with DEB-TACE using 40-µm microspheres

11/2020

Researchers at the University Hospital Jena analyzed the response rate and safety of superselective drug-eluting beads transarterial chemoembolization…

University Hospital Tübingen: Study examined correlation between 18f-fdg PET and CT texture parameters in metastatic melanoma patients

11/2020

An exploratory study [1] conducted by researchers at University Hospital Tuebingen investigated whether CT texture analysis parameters correlate with…

Name	Purpose	Lifetime	Type	Provider
CookieConsent	Saves your consent to using cookies.	1 year	HTML	Website
fe_typo_user	Assigns your browser to a session on the server.	session	HTTP	Website

Name	Purpose	Lifetime	Type	Provider
_pk_id	Used to store a few details about the user such as the unique visitor ID.	13 months	HTML	Matomo
_pk_ref	Used to store the attribution information, the referrer initially used to visit the website.	6 months	HTML	Matomo
_pk_ses	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_cvar	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo
_pk_hsr	Short lived cookie used to temporarily store data for the visit.	30 minutes	HTML	Matomo

Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.